0521779407-13 CUNY1086/Karliner 0 521 77940 7 June 4, 2007 21:15
Localized Scleroderma Low-Oxygen-Affinity Hemoglobins 917
■Phototherapy and photochemotherapy
➣UVA1 therapy, bath PUVA, topical PUVA (psoralen+UVA pho-
totherapy)
➣Must be administered in specialized centers
➣Treatments administered 2–4 times/week over months
➣Risk of burning, secondary skin malignancies
■Methotrexate with or without systemic corticosteroids has been
reported to be useful in a limited number of patients
follow-up
During Treatment
■Re-evaluate skin lesions every 1–3 months during treatment to mon-
itor efficacy of treatment and to note side effects
complications and prognosis
Complications
■Cosmetic concerns; disfigurement resulting from atrophy and pig-
mentary changes
■Contractures and limited mobility if involvement extends over a joint
■In severe cases, muscle atrophy
Prognosis
■Good, with spontaneous remission of disease in most
■May remit in few months or years
■Atrophy and pigmentary changes (hypo- or hyper-) may persist
LOW-OXYGEN-AFFINITY HEMOGLOBINS
AKIKO SHIMAMURA, MD, PhD
history & physical
History
■Positive family history (autosomal dominant inheritance)
■Generally asymptomatic (normal tissue oxygen delivery)
Signs & Symptoms
■Cyanosis may be present
tests
Blood
■Sometimes associated with mild hemolytic anemia